These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 25248004

  • 1. Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD.
    Amin J, Huang B, Yoon J, Shih DQ.
    Inflamm Bowel Dis; 2015 Feb; 21(2):445-52. PubMed ID: 25248004
    [Abstract] [Full Text] [Related]

  • 2. Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease.
    Bradford K, Shih DQ.
    World J Gastroenterol; 2011 Oct 07; 17(37):4166-73. PubMed ID: 22072847
    [Abstract] [Full Text] [Related]

  • 3. Optimizing thiopurine therapy in inflammatory bowel disease.
    Chevaux JB, Peyrin-Biroulet L, Sparrow MP.
    Inflamm Bowel Dis; 2011 Jun 07; 17(6):1428-35. PubMed ID: 20949566
    [Abstract] [Full Text] [Related]

  • 4. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.
    Teml A, Schaeffeler E, Herrlinger KR, Klotz U, Schwab M.
    Clin Pharmacokinet; 2007 Jun 07; 46(3):187-208. PubMed ID: 17328579
    [Abstract] [Full Text] [Related]

  • 5. Addition of Allopurinol for Altering Thiopurine Metabolism to Optimize Therapy in Patients with Inflammatory Bowel Disease.
    Wall GC, Muktar H, Effken C, Mahajan PB.
    Pharmacotherapy; 2018 Feb 07; 38(2):259-270. PubMed ID: 29197117
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
    Hoentjen F, Seinen ML, Hanauer SB, de Boer NK, Rubin DT, Bouma G, Harrell LE, van Bodegraven AA.
    Inflamm Bowel Dis; 2013 Feb 07; 19(2):363-9. PubMed ID: 22605661
    [Abstract] [Full Text] [Related]

  • 8. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases.
    Serpico MR, Maltz R, Crandall W, Bricker J, Dotson JL, Kim SC, Boyle B.
    J Pediatr Gastroenterol Nutr; 2018 Sep 07; 67(3):341-345. PubMed ID: 29601433
    [Abstract] [Full Text] [Related]

  • 9. [Monitoring of thiopurine methyltransferase and thiopurine metabolites to optimize azathioprine therapy in inflammatory bowel disease].
    Gisbert JP, González-Lama Y, Maté J.
    Gastroenterol Hepatol; 2006 Nov 07; 29(9):568-83. PubMed ID: 17129552
    [Abstract] [Full Text] [Related]

  • 10. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
    Hande S, Wilson-Rich N, Bousvaros A, Zholudev A, Maurer R, Banks P, Makrauer F, Reddy S, Burakoff R, Friedman S.
    Inflamm Bowel Dis; 2006 Apr 07; 12(4):251-7. PubMed ID: 16633046
    [Abstract] [Full Text] [Related]

  • 11. Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).
    Friedman AB, Brown SJ, Bampton P, Barclay ML, Chung A, Macrae FA, McKenzie J, Reynolds J, Gibson PR, Hanauer SB, Sparrow MP.
    Aliment Pharmacol Ther; 2018 Apr 07; 47(8):1092-1102. PubMed ID: 29468701
    [Abstract] [Full Text] [Related]

  • 12. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety.
    Dubinsky MC.
    Clin Gastroenterol Hepatol; 2004 Sep 07; 2(9):731-43. PubMed ID: 15354273
    [Abstract] [Full Text] [Related]

  • 13. Clinical Value of Mercaptopurine After Failing Azathioprine Therapy in Patients With Inflammatory Bowel Disease.
    Meijer B, Seinen ML, Leijte NN, Mulder CJ, van Bodegraven AA, de Boer NK.
    Ther Drug Monit; 2016 Aug 07; 38(4):463-70. PubMed ID: 27158876
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD.
    Spencer E, Norris E, Williams C, Dubinsky MC.
    Inflamm Bowel Dis; 2019 Jan 01; 25(1):142-149. PubMed ID: 29920603
    [Abstract] [Full Text] [Related]

  • 16. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD.
    Seidman EG.
    Rev Gastroenterol Disord; 2003 Jan 01; 3 Suppl 1():S30-8. PubMed ID: 12684587
    [Abstract] [Full Text] [Related]

  • 17. Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?
    Meijer B, Seinen ML, van Egmond R, Bouma G, Mulder CJJ, van Bodegraven AA, de Boer NKH.
    Inflamm Bowel Dis; 2017 Nov 01; 23(11):2011-2017. PubMed ID: 28617756
    [Abstract] [Full Text] [Related]

  • 18. Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease.
    Ansari A, Patel N, Sanderson J, O'Donohue J, Duley JA, Florin TH.
    Aliment Pharmacol Ther; 2010 Mar 01; 31(6):640-7. PubMed ID: 20015102
    [Abstract] [Full Text] [Related]

  • 19. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
    Gearry RB, Barclay ML.
    J Gastroenterol Hepatol; 2005 Aug 01; 20(8):1149-57. PubMed ID: 16048561
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.